[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
date : 4/19/2024
Tags: NCDs, Precision Cancer Medicine
Health and Global Institute (HGPI) hosted the Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine in both on-site and online (Hybrid) format on April 4th, 2024.
In the field of oncology, “Cancer Genomic Medicine” has already been actively adopted into routine clinical practice in some countries. There are high expectations that cancer genomic medicine has the potential to fundamentally change the cancer treatment strategy for individual patients in the future.
At this meeting, since ensuring equitable patient access to cancer genomic medicine, including cancer genetic panel testing and subsequent treatment, has become a global topic of discussion, multi-stakeholders were invited, discussing about the latest initiatives in the UK and Japan.
The panel discussion at this meeting focused on the following issues
- Geographic and informational barriers to participation in tests and clinical trials.
- How industry-government-academia-industry collaboration can help remove bottlenecks to patient access.
- Assessment and institutional design measures to ensure access to appropriate tests and treatments at the right time.
- Actions to disseminate and scale up advanced technologies for general use.
[Event Overview]
- Date & Time: Thursday, April 4, 2024; from 15:30 to 19:00 JST / from 7:30 to 11:00 GMT (Open: 15:00 JST / 7:00 GMT)
- Format: Hybrid (In-Person and Online (Zoom Webinars))
- Venue: Global Business Hub Tokyo Field
(Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, JAPAN 100-0004) - Languages: Japanese and English (with simultaneous interpretation)
- Participation fee: Free
- Hosted by: Health and Global Policy Institute
- Supported by: The British Embassy Tokyo
- Sponsored by: AstraZeneca K.K., National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP), Philips Japan, Ltd.
[Program] (Titles omitted; in no particular order)
15:30-15:40 | Opening Remarks |
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute) | |
15:40-16:00 | Keynote Speech 1: Genomic Cancer Medicine in Japan |
Hitoshi Nakagama (President, National Cancer Center) | |
16:00-16:20 | Keynote Speech 2: Genomic Cancer Medicine in the UK |
Dame Sue Hill (Chief Scientific Officer, England and Senior Responsible Officer for Genomics, NHS) | |
– Break (10 mins) – | |
16:30-17:10 | Round Table Discussion 1 “Tackling Regional Disparities in Patient Access to Genomic Cancer Medicine” |
Panelists Moderator |
|
17:10-17:50 | Round Table Discussion 2 “Optimizing Financial and Institutional Support for Innovation” |
Panelists Moderator
|
|
17:50-18:00 | Closing Remarks |
Margaret Tongue (Minister-Counsellor Economic Diplomacy, British Embassy Tokyo) | |
18:00-19:00 | Networking Reception |
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
Featured Posts
-
2024-04-18
[Event Report] NCDs-related Cross-project Meeting: The 2nd Meeting on Non-Communicable Disease in Hokkaido and Tohoku (March 15, 2024)
-
2024-04-22
[Activity Report] Health Information Project Global Sage Meetings for “Co-creating Health Information Right” (April 22, 2024)
-
2024-04-23
[Registration Open] The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-24
[Public Comment Submission] “The Sixth Basic Environment Plan (Draft)” (April 10, 2024)